Synergy Pharmaceuticals Inc

Type: Company
Name: Synergy Pharmaceuticals Inc
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Synergy Pharmaceuticals Q2 net loss up

(MarketLine via COMTEX News Network) -- Synergy Pharmaceuticals Inc., a biopharmaceutical company, has reported that net loss for the second quarter ended June 30, 2014 was $25.92 million, or $0.28 loss per share, compared to a net loss of $10.04 million, ... [Published PredictWallStreet - Aug 27 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Synergy Pharmaceuticals : Reports Second Quarter and First Half 2014 Financial Results

By a News Reporter-Staff News Editor at Clinical Trials Week -- Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), reported its financial results and business update for the three and six months ended June 30, 2014 . Key Development Highlights: On April 28, ... [Published 4 Traders - Aug 20 2014]
First reported Aug 16 2014 - Updated Aug 16 2014 - 2 reports

Trouble For Synergy Pharmaceuticals Shorts With Pending SP-333 Trial Results

By Frank Aldridge :I wrote an article about Synergy Pharmaceuticals (NASDAQ: SGYP ) ("Synergy" or "the company") in November of last year right before the stock made a significant move leading up to Phase 2 IBS -C results. You can refer to my previous ... [Published BioPortfolio - Aug 16 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Synergy Pharmaceuticals Stock Price Down 6.3% on Disappointing Earnings (SGYP)

Shares of Synergy Pharmaceuticals (NASDAQ:SGYP) fell 6.3% on Tuesday following a dissappointing earnings announcement, reports. The company traded as low as $3.50 and last traded at $3.55, with a volume of 494,869 shares trading hands. The stock had previously ... [Published American Banking News - Aug 12 2014]
First reported Aug 11 2014 - Updated Aug 11 2014 - 1 reports

Synergy Pharma EPS of -$0.28

17:44 ET | About: Synergy Pharmaceuticals, Inc. (SGYP)Synergy Pharma (NASDAQ:SGYP): Q2 EPS of -$0.28 may not be comparable to consensus of -$ ... [Published Seeking Alpha - Aug 11 2014]
First reported Aug 11 2014 - Updated Aug 11 2014 - 1 reports

Synergy Pharmaceuticals Reports Second Quarter and First Half 2014 Financial Results

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Reports Second Quarter and First Half 2014 Financial Results ... [Published Business Wire Health News - Aug 11 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 2 reports

Synergy Pharmaceuticals To Present At Growth Conference

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), today announced its Chairman and Chief Executive Officer, Dr. Gary S. Jacob, will present a corporate update at the Canaccord Genuity Growth Conference on Thursday, August 14, 2014 from 3:00 to 3:25 pm (ET) ... [Published BioSpace - Aug 06 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Synergy Pharmaceuticals to Present at Canaccord Genuity Growth Conference

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals to Present at Canaccord Genuity Growth Conference ... [Published Business Wire Health News - Aug 06 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

Anacor Pharmaceuticals, Inc. (ANAC) in Focus: Stock Surges 6.76% - Tale of the Tape

Anacor Pharmaceuticals, Inc. ( ANAC ) was a big mover last session, as the company saw its shares surge nearly 7% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, ... [Published Zacks.com - Jul 22 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 2 reports

Synergy Pharmaceuticals Reaches Halfway Mark for the First Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Reaches Halfway Mark for the First Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation ... [Published Business Wire Science: Science News - Jul 14 2014]
First reported May 15 2014 - Updated May 15 2014 - 4 reports

Synergy Pharmaceuticals’ Chairman and CEO, Dr. Gary S. Jacob, Awarded Honorary Degree by the University of Missouri – St. Louis

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals’ Chairman and CEO, Dr. Gary S. Jacob, Awarded Honorary Degree by the University of Missouri – St. Louis ... [Published Business Wire Photo/Multimedia News - May 15 2014]
First reported May 13 2014 - Updated May 13 2014 - 3 reports

Synergy Pharmaceuticals Reports First Quarter 2014 Financial Results: Cash and Investments Increase to $70.6 million as of March 31, 2014

NEW YORK--(EON: Enhanced Online News)--Synergy Pharmaceuticals Reports First Quarter 2014 Financial Results: Cash and Investments Increase to $70.6 million as of March 31, 2014 ... [Published EON Business - May 13 2014]

Quotes

...Gary Jacob, Chairman and CEO of Synergy. "We remain focused on the successful execution of our clinical programs as we enter the second half of this year and look to start our second registration program with plecanatide in IBS-C and continue to advance the ongoing pivotal phase 3 CIC trials toward our anticipated NDA filing next year."
...Allergan said the offer by Valeant Pharmaceuticals and William Ackman "substantially undervalues Allergan and is not in the best interests of the company and its stockholders." ( http://r.reuters.com/xyg39v )

More Content

All (64) | News (20) | Reports (0) | Blogs (44) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Synergy Pharmaceuticals Q2 net loss up [Published PredictWallStreet - Aug 27 2014]
Synergy Pharmaceuticals : Reports Second Quarte... [Published 4 Traders - Aug 20 2014]
10.3% of XBI Holdings Seeing Recent Insider Buys [Published Self Directed Investor - Aug 18 2014]
Trouble For Synergy Pharmaceuticals Shorts With... [Published BioPortfolio - Aug 16 2014]
Trouble For Synergy Pharmaceuticals Shorts With... [Published Seeking Alpha - Aug 16 2014]
Synergy Pharma (SGYP) Posts Wider-than-Expected... [Published Zacks.com - Aug 13 2014]
Synergy Pharmaceuticals Stock Price Down 6.3% o... [Published American Banking News - Aug 12 2014]
Frontrunning: August 12 [Published Zero Hedge - Aug 12 2014]
Synergy Pharma EPS of -$0.28 [Published Seeking Alpha - Aug 11 2014]
Synergy Pharmaceuticals Reports Second Quarter ... [Published Business Wire Health News - Aug 11 2014]
Synergy Pharmaceuticals To Present At Growth Co... [Published BioSpace - Aug 06 2014]
Synergy Pharmaceuticals to Present at Canaccord... [Published Wall Street Select - Aug 06 2014]
Synergy Pharmaceuticals to Present at Canaccord... [Published Business Wire Health News - Aug 06 2014]
Anacor's Kerydin to Be Commercialized by Sandoz... [Published Nasdaq - Jul 22 2014]
Jazz Pharmaceuticals/Concert Pharmaceuticals St... [Published Yahoo! Finance - Jul 22 2014]
Anacor's Kerydin to Be Commercialized by Sandoz... [Published Yahoo! Finance - Jul 22 2014]
Anacor Pharmaceuticals, Inc. (ANAC) in Focus: S... [Published Zacks.com - Jul 22 2014]
Anacor Pharmaceuticals, Inc. (ANAC) in Focus: S... [Published Yahoo! Finance - Jul 22 2014]
Astellas Up on Pipeline Update, Oncology in Foc... [Published Zacks.com - Jul 21 2014]
Astellas Up on Pipeline Update, Oncology in Foc... [Published Yahoo! Finance - Jul 21 2014]
Synergy closes patient enrollment in Phase II t... [Published PBR - News - Jul 21 2014]
Synergy Pharmaceuticals Completes Patient Enrol... [Published Business Wire Health News - Jul 17 2014]
Synergy Pharmaceuticals Reaches Halfway Mark fo... [Published Business Wire Science: Science News - Jul 14 2014]
Synergy Pharmaceuticals Reaches Halfway Mark fo... [Published Business Wire Health News - Jul 14 2014]
Synergy Pharmaceuticals Announces Successful En... [Published Business Wire Health News - Jul 08 2014]
Synergy Pharmaceuticals’ Chairman and CEO, Dr. ... [Published Business Wire Photo/Multimedia News - May 15 2014]
Synergy Pharmaceuticals’ Chairman and CEO, Dr. ... [Published Business Wire Education News - May 15 2014]
Synergy Pharmaceuticals’ Chairman and CEO, Dr. ... [Published Business Wire Health News - May 15 2014]
Synergy Pharmaceuticals’ Chairman and CEO, Dr. ... [Published Business Wire News with Multimedia - May 15 2014]
Synergy Pharmaceuticals to Present at 2014 UBS ... [Published Business Wire Health News - May 14 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Frontrunning: August 12 [Published Zero Hedge - Aug 12 2014]
Gunshots, tear gas in riots over shooting of black Missouri teen ( Reuters ) Russia sends big aid convoy to Ukraine, West sounds warnings ( Reuters ) Maliki Bid to Block Successor Escalates Crisis in Iraq ( BBG ) Poor German data pushes euro toward 9-month ...
Synergy Pharmaceuticals Reports Second Quarter ... [Published Business Wire Health News - Aug 11 2014]
NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Reports Second Quarter and First Half 2014 Financial Results ...
Synergy Pharmaceuticals to Present at Canaccord... [Published Business Wire Health News - Aug 06 2014]
NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals to Present at Canaccord Genuity Growth Conference ...
Synergy closes patient enrollment in Phase II t... [Published PBR - News - Jul 21 2014]
US-based Synergy Pharmaceuticals has completed patient enrollment in its Phase II trial of SP-333, its next-generation uroguanylin analog, in patients with opioid-induced constipation (OIC). ...
Synergy Pharmaceuticals Completes Patient Enrol... [Published Business Wire Health News - Jul 17 2014]
NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Completes Patient Enrollment for its SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation ...
1 2 3 4 5 6 7 8 9
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.